Stains
Ki67 / MIB1

Author: Monika Roychowdhury, M.D.
Deputy Editor Review: Debra Zynger, M.D.

Revised: 16 May 2018, last major update March 2018

Copyright: (c) 2002-2018, PathologyOutlines.com, Inc.

PubMed Search: (Ki67[title] OR MIBI[title]) stain

Cite this page: Roychowdhury, M. Ki67. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/stainski67.html. Accessed August 18th, 2018.
Definition / general
  • Marker of cell proliferation first described in 1983 (Int J Cancer 1983;31:13)
  • Name derived from Kiel, Germany (city of origin) and the clone number in the 96 well plate (Wikipedia)
  • Labile, nonhistone nuclear protein expressed in G1, S, G2 and M phases of cell cycle, then rapidly catabolized at end of M phase and not detectable in G0 and early G1 cells (J Cell Physiol 2000;182:311)
  • MIB1 is the IgG1 antibody against Ki67 for formalin fixed, paraffin embedded tissue
Essential features
  • Marker of cell proliferation
  • Nuclear stain
  • Considered a prognostic factor of breast cancer
  • Included in Oncotype DX® (21 prospectively selected genes to predict risk of recurrence and chemotherapy benefit in node negative, ER+ women)
Prognostic factors
  • Used for prognosis of relative responsiveness, resistance to chemotherapy or endocrine therapy and biomarker of treatment efficacy (high percentage reflects worse prognosis)
Uses by pathologists
Microscopic (histologic) description
  • Percentage of nuclei with positive staining in tumor cells are scored
    • < 10% - low
    • 10 - 20% - borderline
    • > 20% - high (some variability in current literature regarding cut offs but > 20% is unanimaously considered high)
Microscopic (histologic) images

Images hosted on PathOut server:


Contributed by
Monika Roychowdhury, M.D.

Invasive ductal carcinoma breast 20x

Invasive ductal carcinoma 20x (Ki67)


Contributed by
Dr. Kaveh Naemi
Irvine, California

Missing Image

Lymph node, Burkitt lymphoma



Case of the Week
#238

Missing Image

Skin, symplastic glomus tumor, toe




Case of the Week
#237

Missing Image

Small bowel, malignant GIST



Case of the Week
#202

Missing Image

Cervix, adenocarcinoma in situ, endocervix


Case of the Week
#194

Missing Image Missing Image

Urethra, clear cell adenocarcinoma


AFIP

Missing Image Missing Image

Lymph node, normal

Contributed by
Leica Microsystems

Missing Image

Tonsil, normal



Images hosted on other servers:
Missing Image Missing Image

Breast, hemangioma vs high grade angiosarcoma

Missing Image Missing Image

Breast, invasive carcinoma, basal-like subtype with high Ki67 index

Missing Image

Breast cancer: luminal A type

Missing Image

Colon, adenomatous vs nonadenomatous polyps


Missing Image

Kidney, malignant solitary fibrous tumor

Missing Image

Lymph node, diffuse large B cell lymphoma

Missing Image

Pancreas, islet cell tumors

Missing Image Missing Image

Uterus (left to right), mid proliferative endometrium, day 17 endometrium



Board review question #1
54 year old woman recently received the diagnosis of invasive ductal carcinoma for a right breast mass. Which of the prognostic markers below, if positive, suggest(s) aggressive behavior of the tumor?

  1. ER
  2. HER2
  3. Ki67
  4. PR
Board review answer #1
B. and C. (HER2 and Ki67)